Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells

Objective: Tamoxifen is currently used for the treatment of estrogen receptor-positive breast cancer patients, but acquired resistance to tamoxifen is a critical problem in breast cancer therapy. Suberoylanilide hydroxamic acid (SAHA) is a prototype of the newly developed HDAC inhibitor. The aim of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Young Ju, Won, A Jin, Lee, Jaewon, Jung, Jee H., Yoon, Sungpil, Lee, Byung Mu, Kim, Hyung Sik
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2012
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3498753/
https://ncbi.nlm.nih.gov/pubmed/23155362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.5011
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak